BIOMAT Database Logo BIOMAT Database Logo

Evolution of Sleep Complaints in Myotonic Dystrophy Type 1: A 9-Year Longitudinal Study. 2024

Luc Laberge, and Alexandre Maltais, and Julie Auclair, and Jean Mathieu, and Cynthia Gagnon
ÉCOBES - Recherche et transfert, Cégep de Jonquière, 2505 Rue Saint Hubert, Jonquière, QuébecG7X 7W2, Canada.

The objective was to characterize the progression of sleep complaints in 115 dystrophy type 1 (DM1) patients who filled out a sleep questionnaire twice at a 9-year interval. Daytime napping (22.1% vs. 34.5%, p < 0.05), early awakenings (11.4% vs 21.1%, p < 0.05), nonrestorative sleep (39.5% vs 51.8%, p < 0.05), stimulant use (7.0% vs 19.3%, p < 0.01), breathing cessation (10.7% vs 23.2%, p < 0.01), and nighttime urination (42.5% vs 54.9%, p < 0.05) increased between Time 1 and Time 2. Sleep-related complaints are prominent and augment rapidly in DM1 patients. Physicians need to better identify and treat them to help alleviate the burden they impose on patients and their caregivers.

UI MeSH Term Description Entries
D006970 Disorders of Excessive Somnolence Disorders characterized by hypersomnolence during normal waking hours that may impair cognitive functioning. Subtypes include primary hypersomnia disorders (e.g., IDIOPATHIC HYPERSOMNOLENCE; NARCOLEPSY; and KLEINE-LEVIN SYNDROME) and secondary hypersomnia disorders where excessive somnolence can be attributed to a known cause (e.g., drug affect, MENTAL DISORDERS, and SLEEP APNEA SYNDROME). (From J Neurol Sci 1998 Jan 8;153(2):192-202; Thorpy, Principles and Practice of Sleep Medicine, 2nd ed, p320) Daytime Sleepiness,Daytime Somnolence,Excessive Daytime Sleepiness,Hypersomnia,Hypersomnolence,Primary Hypersomnia Disorders,Secondary Hypersomnia Disorders,DOES (Disorders of Excessive Somnolence),Excessive Somnolence Disorders,Hypersomnia, Recurrent,Hypersomnolence Disorders,Hypersomnolence Disorders, Primary,Hypersomnolence Disorders, Secondary,Primary Hypersomnolence Disorders,Secondary Hypersomnolence Disorders,DOESs (Disorders of Excessive Somnolence),Daytime Sleepiness, Excessive,Daytime Sleepinesses,Daytime Somnolences,Excessive Daytime Sleepinesses,Excessive Somnolence Disorder,Hypersomnia Disorder, Primary,Hypersomnia Disorder, Secondary,Hypersomnias,Hypersomnolence Disorder,Hypersomnolence Disorder, Primary,Hypersomnolence Disorder, Secondary,Primary Hypersomnia Disorder,Primary Hypersomnolence Disorder,Recurrent Hypersomnia,Recurrent Hypersomnias,Secondary Hypersomnia Disorder,Secondary Hypersomnolence Disorder,Sleepiness, Daytime,Sleepiness, Excessive Daytime,Somnolence Disorder, Excessive,Somnolence, Daytime
D008137 Longitudinal Studies Studies in which variables relating to an individual or group of individuals are assessed over a period of time. Bogalusa Heart Study,California Teachers Study,Framingham Heart Study,Jackson Heart Study,Longitudinal Survey,Tuskegee Syphilis Study,Bogalusa Heart Studies,California Teachers Studies,Framingham Heart Studies,Heart Studies, Bogalusa,Heart Studies, Framingham,Heart Studies, Jackson,Heart Study, Bogalusa,Heart Study, Framingham,Heart Study, Jackson,Jackson Heart Studies,Longitudinal Study,Longitudinal Surveys,Studies, Bogalusa Heart,Studies, California Teachers,Studies, Jackson Heart,Studies, Longitudinal,Study, Bogalusa Heart,Study, California Teachers,Study, Longitudinal,Survey, Longitudinal,Surveys, Longitudinal,Syphilis Studies, Tuskegee,Syphilis Study, Tuskegee,Teachers Studies, California,Teachers Study, California,Tuskegee Syphilis Studies
D009223 Myotonic Dystrophy Neuromuscular disorder characterized by PROGRESSIVE MUSCULAR ATROPHY; MYOTONIA, and various multisystem atrophies. Mild INTELLECTUAL DISABILITY may also occur. Abnormal TRINUCLEOTIDE REPEAT EXPANSION in the 3' UNTRANSLATED REGIONS of DMPK PROTEIN gene is associated with Myotonic Dystrophy 1. DNA REPEAT EXPANSION of zinc finger protein-9 gene intron is associated with Myotonic Dystrophy 2. Dystrophia Myotonica,Myotonic Dystrophy, Congenital,Myotonic Myopathy, Proximal,Steinert Disease,Congenital Myotonic Dystrophy,Dystrophia Myotonica 1,Dystrophia Myotonica 2,Myotonia Atrophica,Myotonia Dystrophica,Myotonic Dystrophy 1,Myotonic Dystrophy 2,PROMM (Proximal Myotonic Myopathy),Proximal Myotonic Myopathy,Ricker Syndrome,Steinert Myotonic Dystrophy,Steinert's Disease,Atrophica, Myotonia,Atrophicas, Myotonia,Congenital Myotonic Dystrophies,Disease, Steinert,Disease, Steinert's,Dystrophia Myotonica 2s,Dystrophia Myotonicas,Dystrophica, Myotonia,Dystrophicas, Myotonia,Dystrophies, Congenital Myotonic,Dystrophies, Myotonic,Dystrophy, Congenital Myotonic,Dystrophy, Myotonic,Dystrophy, Steinert Myotonic,Myopathies, Proximal Myotonic,Myopathy, Proximal Myotonic,Myotonia Atrophicas,Myotonia Dystrophicas,Myotonic Dystrophies,Myotonic Dystrophies, Congenital,Myotonic Dystrophy, Steinert,Myotonic Myopathies, Proximal,Myotonica, Dystrophia,Myotonicas, Dystrophia,PROMMs (Proximal Myotonic Myopathy),Proximal Myotonic Myopathies,Steinerts Disease,Syndrome, Ricker
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012890 Sleep A readily reversible suspension of sensorimotor interaction with the environment, usually associated with recumbency and immobility. Sleep Habits,Sleeping Habit,Sleeping Habits,Habit, Sleep,Habit, Sleeping,Habits, Sleep,Habits, Sleeping,Sleep Habit

Related Publications

Luc Laberge, and Alexandre Maltais, and Julie Auclair, and Jean Mathieu, and Cynthia Gagnon
Cognitive decline over time in adults with myotonic dystrophy type 1: A 9-year longitudinal study.
January 2017, Neuromuscular disorders : NMD,
Luc Laberge, and Alexandre Maltais, and Julie Auclair, and Jean Mathieu, and Cynthia Gagnon
Progressive Decline in Daily and Social Activities: A 9-year Longitudinal Study of Participation in Myotonic Dystrophy Type 1.
September 2019, Archives of physical medicine and rehabilitation,
Luc Laberge, and Alexandre Maltais, and Julie Auclair, and Jean Mathieu, and Cynthia Gagnon
Sleep Complaints, Sleep and Breathing Disorders in Myotonic Dystrophy Type 2.
February 2019, Current neurology and neuroscience reports,
Luc Laberge, and Alexandre Maltais, and Julie Auclair, and Jean Mathieu, and Cynthia Gagnon
Predicting daytime sleepiness and fatigue: a 9-year prospective study in myotonic dystrophy type 1.
February 2020, Journal of neurology,
Luc Laberge, and Alexandre Maltais, and Julie Auclair, and Jean Mathieu, and Cynthia Gagnon
Sleep complaints in patients with myotonic dystrophy.
March 2004, Journal of sleep research,
Luc Laberge, and Alexandre Maltais, and Julie Auclair, and Jean Mathieu, and Cynthia Gagnon
A 9-year follow-up study of quantitative muscle strength changes in myotonic dystrophy type 1.
July 2018, Journal of neurology,
Luc Laberge, and Alexandre Maltais, and Julie Auclair, and Jean Mathieu, and Cynthia Gagnon
Fatigue in myotonic dystrophy type 1: a seven-year prospective study.
December 2019, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology,
Luc Laberge, and Alexandre Maltais, and Julie Auclair, and Jean Mathieu, and Cynthia Gagnon
Age-related cognitive decline in myotonic dystrophy type 1: An 11-year longitudinal follow-up study.
March 2020, Journal of neuropsychology,
Luc Laberge, and Alexandre Maltais, and Julie Auclair, and Jean Mathieu, and Cynthia Gagnon
Cognition in myotonic dystrophy type 1: a 5-year follow-up study.
September 2016, European journal of neurology,
Luc Laberge, and Alexandre Maltais, and Julie Auclair, and Jean Mathieu, and Cynthia Gagnon
Cognitive impairment in myotonic dystrophy type 1 (DM1): a longitudinal follow-up study.
November 2008, Journal of neurology,
Copied contents to your clipboard!